Article metrics

Download PDFPDF

617 A Phase I study of a tumor-targeted, fibroblast activation protein (FAP)-CD40 agonist (RO7300490) in patients with advanced solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023378035
Dec 2023159044
Jan 20246005
Feb 2024272033
Mar 2024154015
Apr 2024222021
May 2024160015
Jun 2024178026
Jul 2024236023
Aug 2024130010
Sep 2024136015
Oct 2024194017
Nov 2024172015
Dec 2024174010
Jan 2025174012
Feb 202578021
Mar 20250019
Apr 2025109
May 20250026
Jun 20250026
Total28780397